Clinical trial: Experimental med for asthma
This Phase II study is designed to assess the effectiveness and safety of the experimental asthma medication JNJ-18054478 when compared with a placebo. This national study is currently recruiting adults ages 18 to 65.
(National Institutes of Health) UPDATED 07/08/2008Click here to read the full story

